EMEA: Reflection paper on risk management plans for centrally authorised veterinary medicinal products
19.11.2009
Veterinary pharmacovigilance is in continuous development. The provision for risk management systems is new in the field of veterinary medicines and therefore gives opportunity for novel, targeted and risk-based approaches to take place in the monitoring and management of safety of authorised medicinal products for veterinary use, as appropriate.
Źródło wiadomośći: http://www.emea.europa.eu/pdfs/vet/regaffair/12672607en.pdf
SciencePharma
